Table 1 Baseline characteristics of gastric cancer patients with positive cytology but without gross peritoneal metastasis treated with surgery and chemotherapy and those treated with surgery alone.
Variables, n (%) | Cytology (+) | P-value | |
|---|---|---|---|
Chemotherapy (+) | Surgery alone | ||
n = 64 (%) | n = 24 (%) | ||
Age (years) | |||
<61 | 35 (54.7) | 8 (33.3) | 0.076 |
≥61 | 29 (45.3) | 16 (66.7) | |
Sex | |||
Male | 47 (73.4) | 19 (79.2) | 0.582 |
Female | 17 (26.6) | 5 (20.8) | |
Tumor location | |||
GEJ, whole stomach | 25 (39.1) | 8 (33.3) | 0.623 |
Body, antrum | 39 (60.9) | 16 (66.7) | |
Tumor grade | |||
Well/moderately differentiated | 11 (17.2) | 10 (41.7) | 0.017 |
Poorly/un-differentiated | 53 (82.3) | 14 (58.3) | |
Lauren classification | |||
Intestinal | 20 (31.3) | 11 (45.8) | 0.205 |
Non-intestinal (diffuse or mixed) | 44 (68.8) | 13 (54.2) | |
T stage | |||
T1/2/3 | 8 (12.5) | 1 (4.2) | 0.253 |
T4 | 56 (81.5) | 23 (95.8) | |
N stage | |||
N0/1/2 | 13 (20.3) | 3 (12.5) | 0.401 |
N3 | 51 (79.7) | 21 (87.5) | |
LVI + /LVI− | 53 (82.8)/11 (17.2) | 13 (54.2)/11 (45.8) | 0.006 |
PNI + /PNI− | 57 (89.1)/7 (10.9) | 22 (91.7)/2 (8.3) | 0.721 |
